Page last updated: 2024-08-25

ubenimex and forphenicinol

ubenimex has been researched along with forphenicinol in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayasaka, K; Ishihara, K; Yamazaki, N1
Umezawa, H1
Miura, K; Sawa, T; Takeuchi, T; Umezawa, H1
Ishizuka, M; Umezawa, H1
Lin, ZB; Shi, JP1
Ishizuka, M1
Aoyagi, T; Harada, S; Kojima, F; Nagai, M; Ohuchi, S; Umezawa, H; Wada, T1

Reviews

2 review(s) available for ubenimex and forphenicinol

ArticleYear
Low-molecular-weight immunomodifiers produced by micro-organisms.
    Biotechnology & genetic engineering reviews, 1985, Volume: 3

    Topics: Alkaline Phosphatase; Aminopeptidases; Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antibody Formation; Diaminopimelic Acid; Glycine; Guanidines; Hypersensitivity, Delayed; Immune Tolerance; Immunity; Immunity, Cellular; Lactones; Leucine; Leukemia L1210; Mice; Molecular Weight; Oligopeptides; Peptides; Polycyclic Sesquiterpenes; Sesquiterpenes; T-Lymphocytes, Regulatory

1985
[Low-molecular weight immunostimulants: cell membrane enzyme inhibitors].
    Sheng li ke xue jin zhan [Progress in physiology], 1985, Volume: 16, Issue:2

    Topics: Adjuvants, Immunologic; Aminopeptidases; Animals; Antineoplastic Agents; Cell Membrane; Dogs; Glycine; Leucine; Mice; Molecular Weight; Rabbits; Rats

1985

Other Studies

5 other study(ies) available for ubenimex and forphenicinol

ArticleYear
Current status of melanoma treatment with interferon, cytokines and other biologic response modifiers in Japan.
    The Journal of investigative dermatology, 1989, Volume: 92, Issue:5 Suppl

    Topics: Biological Factors; Biological Products; Cell Wall Skeleton; Cytokines; DNA, Bacterial; Glycine; Humans; Interferon Type I; Interferon-gamma; Interferons; Interleukin-2; Leucine; Male; Melanoma; Middle Aged; Mucoproteins; Mycolic Acids; Picibanil; Recombinant Proteins; Skin Neoplasms; Tumor Necrosis Factor-alpha

1989
Effects of enzyme inhibitors in inhibiting the growth and inducing the differentiation of human promyelocytic leukemia cells, HL-60.
    The Journal of antibiotics, 1986, Volume: 39, Issue:5

    Topics: Anti-Bacterial Agents; Cell Differentiation; Cell Line; Enzyme Inhibitors; Glycine; Guanidines; Humans; Leucine; Leukemia, Myeloid, Acute; Oligopeptides; Peptides; Protease Inhibitors

1986
Low molecular weight immunomodifiers produced by microorganisms.
    International journal of clinical pharmacology, therapy, and toxicology, 1985, Volume: 23 Suppl 1

    Topics: Adjuvants, Immunologic; Aminopeptidases; Animals; Antibiotics, Antineoplastic; Glycine; Guanidines; Humans; Leucine; Molecular Weight

1985
[Low molecular weight immunomodulators produced by microorganisms].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:12 Pt 2

    Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Concanavalin A; Glycine; Leucine; Lymphocyte Activation; Mice; Molecular Weight; Naphthacenes; Neoplasms, Experimental; Ribonucleosides

1984
Similar effects of various low-molecular-weight enzyme inhibitors on enzyme networks in dystrophic mice.
    Journal of pharmacobio-dynamics, 1984, Volume: 7, Issue:9

    Topics: Alkaline Phosphatase; Aminopeptidases; Animals; Esterases; Forelimb; Glutamyl Aminopeptidase; Glycine; Hindlimb; Leucine; Leucyl Aminopeptidase; Leupeptins; Male; Mice; Mice, Mutant Strains; Molecular Weight; Muscles; Muscular Dystrophy, Animal; Oligopeptides; Spleen

1984